126 related articles for article (PubMed ID: 2621112)
1. In vivo assessment of 6-deoxy-6-[18F]fluoro-D-galactose as a PET tracer for studying galactose metabolism.
Ishiwata K; Tomura M; Ido T; Iwata R; Itoh J; Kameyama M
Int J Rad Appl Instrum B; 1989; 16(8):775-81. PubMed ID: 2621112
[TBL] [Abstract][Full Text] [Related]
2. 2-Deoxy-2-[18F]fluoro-D-galactose as an in vivo tracer for imaging galactose metabolism in tumors with positron emission tomography.
Ishiwata K; Yamaguchi K; Kameyama M; Fukuda H; Tada M; Matsuzawa T; Muraishi K; Itoh J; Kawashima K; Takahashi T
Int J Rad Appl Instrum B; 1989; 16(3):247-54. PubMed ID: 2785512
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of 2-deoxy-2-[18F]fluoro-D-galactose in the liver by phosphate and uridylate trapping.
Ishiwata K; Ido T; Imahori Y; Yamaguchi K; Fukuda H; Tada M; Matsuzawa T
Int J Rad Appl Instrum B; 1988; 15(3):271-6. PubMed ID: 3260229
[TBL] [Abstract][Full Text] [Related]
4. 6-[18F]fluoro-L-fucose: a possible tracer for assessing glycoconjugate synthesis in tumors with positron emission tomography.
Ishiwata K; Tomura M; Ido T; Iwata R; Sato K; Hatazawa J; Kameyama M; Imahori Y
J Nucl Med; 1990 Dec; 31(12):1997-2003. PubMed ID: 2266399
[TBL] [Abstract][Full Text] [Related]
5. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T
Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872
[TBL] [Abstract][Full Text] [Related]
6. 2-Deoxy-2-[18F]fluoro-D-galactose: a new tracer for the measurement of galactose metabolism in the liver by positron emission tomography.
Fukuda H; Matsuzawa T; Tada M; Takahashi T; Ishiwata K; Yamada K; Abe Y; Yoshioka S; Sato T; Ido T
Eur J Nucl Med; 1986; 11(11):444-8. PubMed ID: 3486765
[TBL] [Abstract][Full Text] [Related]
7. Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography.
Sørensen M; Munk OL; Mortensen FV; Olsen AK; Bender D; Bass L; Keiding S
Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G27-G36. PubMed ID: 18483186
[TBL] [Abstract][Full Text] [Related]
8. Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT.
Sørensen M; Mikkelsen KS; Frisch K; Bass L; Bibby BM; Keiding S
J Nucl Med; 2011 Oct; 52(10):1566-72. PubMed ID: 21875925
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and actions of 2-deoxy-2-fluoro-D-galactose in vivo.
Grün BR; Berger U; Oberdorfer F; Hull WE; Ostertag H; Friedrich E; Lehmann J; Keppler D
Eur J Biochem; 1990 May; 190(1):11-9. PubMed ID: 2114284
[TBL] [Abstract][Full Text] [Related]
10. In vivo metabolism and UTP-depleting action of 2-deoxy-2-fluoro-D-galactose.
Grün BR; Berger U; Oberdorfer F; Hull WE; Ostertag H; Keppler D
Adv Enzyme Regul; 1990; 30():231-42. PubMed ID: 2403033
[TBL] [Abstract][Full Text] [Related]
11. The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
Mikkelsen KS; Sørensen M; Frisch K; Villadsen GE; Bibby BM; Keiding S
J Nucl Med; 2014 Apr; 55(4):590-4. PubMed ID: 24591487
[TBL] [Abstract][Full Text] [Related]
12. Imaging of rats with mammary cancer with two 2-deoxy-2-[18F]fluoro-D-hexoses.
Paul R; Aho K; Bergman J; Haaparanta M; Kulmala J; Reissell A; Solin O
Int J Rad Appl Instrum B; 1989; 16(5):449-53. PubMed ID: 2509402
[TBL] [Abstract][Full Text] [Related]
13. High accumulation of 2-deoxy-2-fluorine-18-fluoro-D-galactose by well-differentiated hepatomas of mice and rats.
Fukuda H; Takahashi J; Fujiwara T; Yamaguchi K; Abe Y; Kubota K; Sato T; Miyazawa H; Hatazawa J; Tada M
J Nucl Med; 1993 May; 34(5):780-6. PubMed ID: 8478711
[TBL] [Abstract][Full Text] [Related]
14. Tumor uptake study of 18F-labeled N-acetylneuraminic acids.
Ishiwata K; Ido T; Nakajima T; Ohrui H; Kijima-Suda I; Itoh M
Int J Rad Appl Instrum B; 1990; 17(4):363-7. PubMed ID: 2387744
[TBL] [Abstract][Full Text] [Related]
15. [2-Deoxy-2-(18F)Fluoro-D-galactose: a new tracer for the evaluation of liver function by PET--I. Evaluation of toxicity and radiation dose].
Fukuda H; Yamaguchi K; Matsuzawa T; Abe Y; Yamada K; Yoshioka S; Sato T; Tada M; Ogata Y; Takahashi T
Kaku Igaku; 1987 Feb; 24(2):165-9. PubMed ID: 3497290
[No Abstract] [Full Text] [Related]
16. Metabolic pathway of 2-deoxy-2-[18F]fluoro-D-talose in mice: trapping in tissue after phosphorylation by galactokinase.
Haradahira T; Maeda M; Kato A; Kanazawa Y; Yamada M; Torii Y; Ichiya Y; Masuda K
Nucl Med Biol; 1994 Feb; 21(2):269-76. PubMed ID: 9234293
[TBL] [Abstract][Full Text] [Related]
17. Nucleophilic radiosynthesis of 2-[18F]fluoro-2-deoxy-D-galactose from Talose triflate and biodistribution in a porcine model.
Frisch K; Bender D; Hansen SB; Keiding S; Sørensen M
Nucl Med Biol; 2011 May; 38(4):477-83. PubMed ID: 21531284
[TBL] [Abstract][Full Text] [Related]
18. 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose.
Bak-Fredslund KP; Munk OL; Keiding S; Sørensen M
Nucl Med Biol; 2016 Sep; 43(9):577-580. PubMed ID: 27434609
[TBL] [Abstract][Full Text] [Related]
19. Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma.
Kaarstad K; Bender D; Bentzen L; Munk OL; Keiding S
J Nucl Med; 2002 Jul; 43(7):940-7. PubMed ID: 12097467
[TBL] [Abstract][Full Text] [Related]
20. Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.
Sørensen M; Mikkelsen KS; Frisch K; Villadsen GE; Keiding S
J Hepatol; 2013 Jun; 58(6):1119-24. PubMed ID: 23339954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
